Price, Feodor D. http://orcid.org/0000-0001-6773-5675
Matyas, Mark N.
Gehrke, Andrew R.
Chen, William http://orcid.org/0000-0001-6374-8807
Wolin, Erica A.
Holton, Kristina M.
Gibbs, Rebecca M.
Lee, Alice
Singu, Pooja S. http://orcid.org/0009-0001-8835-4123
Sakakeeny, Jeffrey S.
Poteracki, James M. http://orcid.org/0000-0001-8144-0662
Goune, Kelsey http://orcid.org/0000-0001-5075-7915
Pfeiffer, Isabella T. http://orcid.org/0009-0005-2512-8400
Boswell, Sarah A. http://orcid.org/0000-0002-3118-3378
Sorger, Peter K. http://orcid.org/0000-0002-3364-1838
Srivastava, Mansi
Pfaff, Kathleen Lindahl
Gussoni, Emanuela http://orcid.org/0000-0002-9915-3677
Buchanan, Sean M.
Rubin, Lee L. http://orcid.org/0000-0002-8658-841X
Funding for this research was provided by:
Blavatnik Biomedical Accelerator Stepping Strong Center for Trauma Innovation National Resilience Inc. Gift to the Harvard Stem Cell Institute from Dr. Priscilla Winn Barlow NIH LINCS Phase II grant
Article History
Received: 28 January 2021
Accepted: 27 June 2024
First Online: 11 September 2024
Competing interests
: A patent is active in the United States (US11512291B2) based on this research. L.L.R. and F.D.P. are co-founders of Circle Therapeutics, Inc. Circle Therapeutics and National Resilience are both interested in developing therapeutics to treat skeletal muscle disorders. L.L.R. is a founder of Vesalius Therapeutics, a member of its scientific advisory board and a private equity shareholder. He is also on the advisory board of Alkahest, a Grifols company, which is focused on the plasma proteome, and is a scientific advisory board member of ProjenX and Corsalex. All are interested in formulating approaches intended to treat diseases of the nervous system and other tissues. With the exception of National Resilience, none of these companies provided any financial support for this work, and the current work is unrelated to work carried out at any of these companies. The remaining authors declare no competing interests.